The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-((2-chlorophenyl)amino)-1H-pyrazolo[3,4-c]pyridin-1-yl)-N-(oxetan-3-yl)thiophene-2-carboxamide ID: ALA4872832
PubChem CID: 156155321
Max Phase: Preclinical
Molecular Formula: C20H16ClN5O2S
Molecular Weight: 425.90
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC1COC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)ncc32)cs1
Standard InChI: InChI=1S/C20H16ClN5O2S/c21-15-3-1-2-4-16(15)25-19-5-12-7-23-26(17(12)8-22-19)14-6-18(29-11-14)20(27)24-13-9-28-10-13/h1-8,11,13H,9-10H2,(H,22,25)(H,24,27)
Standard InChI Key: XXPJQSSWRLLVEZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
2.9551 -13.5373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6628 -13.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2474 -13.1287 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9551 -14.3545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2474 -12.3115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8269 -11.7290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2491 -11.1512 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6712 -11.7290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4115 -13.4621 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.9583 -12.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5497 -12.1470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7504 -12.3170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8820 -11.4004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0168 -10.0896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4702 -10.6970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7603 -10.4209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6763 -11.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3397 -11.7150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0874 -11.3793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1677 -10.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5034 -10.0852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9118 -10.2224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5764 -10.6979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4940 -11.5119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1578 -11.9872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9029 -11.6495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9802 -10.8317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3155 -10.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7493 -11.8483 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 5 1 0
2 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 2 2 0
11 13 1 0
13 17 1 0
16 14 1 0
14 15 2 0
15 13 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
24 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 425.90Molecular Weight (Monoisotopic): 425.0713AlogP: 4.01#Rotatable Bonds: 5Polar Surface Area: 81.07Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.99CX LogP: 3.33CX LogD: 3.33Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.65
References 1. Feng Y, Park H, Ryu JC, Yoon SO.. (2021) N -Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors., 12 (10.0): [PMID:34676036 ] [10.1021/acsmedchemlett.1c00334 ]